Cowan, James F <br/><br/>
Clinical Impact and Cost-effectiveness of Xpert MTB/RIF Testing in Hospitalized Patients With Presumptive Pulmonary Tuberculosis in the United States.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  02 2017 
 - 482-489 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1537-6591 
<br/><br/><label>Standard No.: </label>10.1093/cid/ciw803  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Cost-Benefit Analysis<br/>DNA, Bacterial<br/>Female<br/>Hospitalization<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Mycobacterium tuberculosis--genetics<br/>Nucleic Acid Amplification Techniques--economics<br/>Prospective Studies<br/>Reproducibility of Results<br/>Sensitivity and Specificity<br/>Sputum--microbiology<br/>Tuberculosis, Pulmonary--diagnosis<br/>Washington<br/>Young Adult